ATTAIN — 3 things I got wrong before I got it right
Trying to settle this properly because the thread from last year went in circles. The claim: small molecule matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 3 months without either producing anything. What would actually settle it is 31 people measuring the…
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
The injection-site soreness was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.
Small correction: the trial was 3 weeks, not 3. Does not change your point but people will quote it.
Yeah, small molecule changes the whole game.
the the food-noise thing profile is speculative at this stage
phase 8 data is interesting, phase 32 will tell the real story
oral non-peptide agonist is ACHIEVE, no food restrictions
This is an urgent-care question wearing a forum question's clothes.
Adding to this: ATTAIN is doing more work than the comment implies.
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
Respectfully this is a sample of one presented as a finding.